glp-1 drugs history The expanding landscape of medicines Another milestone in the evolution
Description
Exenatide once weekly for the treatment of type 2 diabetes
Collins FW et al
This part of the guideline is silly because there is no way to risk stratify these patients using the stated risk factors
Dual Amylin and Calcitonin Receptor Agonists Inspired by the pharmacology of salmon calcitonin, DACRAs for the treatment of obesity and diabetes have been developed (155)
& Girardi, A
Several factors may explain why CVOTs have not demonstrated more robust or statistically significant results with combination therapy
